Evidence map›Paper›PMID 32445403›Full record

ReviewScandinavian journal of immunology2020

SARS-CoV-2 infection-induced immune responses: Friends or foes?

Keying Li, Zhenhua Hao, Xiaohui Zhao, Jiying Du, Yanlin Zhou

Open access · bronzeAbstract readReview
In one paragraph

Review in Scandinavian journal of immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Review
  6. Review
  7. Review
  8. SARS-CoV-2 vaccination and uveitis: Are they linked?Annals of medicine and surgery (2012) · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Keying LiDepartment of Medical Laboratory, Sanquan College of Xinxiang Medical University, Xinxiang, China.ORCID https://orcid.org/0000-0003-4934-7489
Zhenhua HaoDepartment of Pathogen Biology and Immunology, Sanquan College of Xinxiang Medical University, Xinxiang, China.ORCID https://orcid.org/0000-0002-9180-4164
Xiaohui ZhaoDepartment of Pathogen Biology and Immunology, Sanquan College of Xinxiang Medical University, Xinxiang, China.ORCID https://orcid.org/0000-0001-6874-1495
Jiying DuDepartment of Medical Laboratory, Sanquan College of Xinxiang Medical University, Xinxiang, China.ORCID https://orcid.org/0000-0003-4082-4605
Yanlin ZhouDepartment of Pathogen Biology and Immunology, Sanquan College of Xinxiang Medical University, Xinxiang, China.ORCID https://orcid.org/0000-0003-3661-7929
Xinxiang Medical University · CN

Funding

Key Science and Technology Project of Henan Province 192102310333Key scientific research projects of Henan Colleges and Universities 19B320015Medical Science and Technology Project Jointly Built of Henan Province 2018020385Undergraduate Innovation and Entrepreneurship Training Program S201913505004
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging coronavirus that belongs to the β-genus, causing the outbreak of coronavirus disease 19 (COVID-19). SARS-CoV-2 infection can stimulate a pronounced immune response in the host, which embodies in the decrease of lymphocytes and aberrant increase of cytokines in COVID-19 patients. SARS-CoV-2 RNA and proteins interact with various pattern recognition receptors that switch on antiviral immune responses to regulate viral replication and spreading within the host in vivo. However, overactive and impaired immune responses also cause immune damage and subsequent tissue inflammation. This article focuses on the dual roles of immune system during SARS-CoV-2 infection, providing a theoretical basic for identifying therapeutic targets in a situation with an unfavourable immune reaction.

Indexed as

Antiviral AgentsBetacoronavirusCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCoronavirus InfectionsCOVID-19Cytokine Release SyndromeCytokinesHost-Pathogen InteractionsHumansPandemicsPneumonia, ViralReceptors, Pattern RecognitionRNA, ViralSARS-CoV-2Signal TransductionAntiviral AgentsCytokinesReceptors, Pattern RecognitionRNA, ViralViral Proteinscoronavirus disease 19cytokine storminflammationsevere acute respiratory syndrome coronavirus 2

Identifiers

PMID32445403
PMCPMC7267129
OpenAlexW3027399327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.